Self-copying RNA vaccine wins first full approval: what's next?

Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making. Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making.

Related Keywords

Maryland ,United States ,United Kingdom ,Brookline ,Massachusetts ,Research Triangle Park ,North Carolina ,Melbourne ,Victoria ,Australia ,Washington ,Canada ,Belgium ,Merelbeke ,Region Flamande ,Vancouver ,British Columbia ,France ,Japan ,San Diego ,California ,India ,Gaithersburg ,Venezuela ,Itiba ,Chiba ,Boston University ,Seattle ,Japanese ,Venezuelan ,British ,Anna Blakney ,Mark Grinstaff ,Corey Casper ,Nathaniel Wang ,Christian Mandl ,Niek Sanders ,Keylicon Biosciences ,Roberta Duncan ,Jonathan Smith ,Pfizer ,Ghent University ,University Of British Columbia ,Access To Advanced Health Institute In Seattle ,Comirnaty Omicron ,Arcturus Therapeutics ,Replicate Bioscience ,Tiba Biotech ,Ziphius Vaccines ,Advanced Health Institute ,